問題一覧
1
gi transit, speed gastric emptying time
prokinetic
2
prokinetic indications
GERD, impaired gastric emptying, vagotomy, antrectomy, diabetic gastroperesis
3
cholinomimetic agents
betanechol, neostigmine
4
muscarinic m3 receptor on myenteric plexus synapse
betanechol
5
acetylcholinisterase inhibitor, ohilvie's syndrome
neostigmine
6
acute colonic pseudoobstruction
ogilvie's syndrome
7
substituted benzamines
metoclopramide, domperidone, cisapride, erythromycin
8
blocks dopamine d2 receptor, anti nausea, antiemetic. includes prolactin, cholinergic smooth muscle stimulation
metoclopramide, domperidone
9
methomoglobinemia
metoclopramide
10
qt interval prolongation, cardiact arrest, sudden death
domperidone
11
5ht4 agonist enteric neurons acetylcholine release 5ht3 antagonist
cisapride
12
parkinsonism syndrome, restlessness
metoclopramide
13
cardiac arrythmias
cisapride
14
directly stimulates motilin receptor onset of migrating motor complex
erythromycin
15
antipsychotic agents potent antiemetic and sedative properties inhibits dopamine and muscarinic antihistamine
phenothiazine
16
dioperidol
butyrophones
17
anti emetic due to dopaminergic blockade metoclopramide and trimethobenzamide dopamine receptor blockade
butyrophones
18
lorazepam and diazepam
benzodiazepines
19
before the initiation of cemotherapy to reduce anticipatory vomiting
benzodiazepines
20
dronabinol
cannabinoids
21
major psychoactive compound
synthetic-9-tetrahydrocannabinoid
22
appetite stimulant
cannabinoids
23
dexamethasone, methylprednisolone
corticosteroids
24
tx of chemo induced vomiting
corticosteroids
25
prototypic muscarinic receptor antagonist most effective for motion sickness
hyoscine
26
prophylaxis of motion sickness clear for tetranogenic potential
dicyclomine
27
h2 antihistamines
cetirizine, cyclizine, dimehydrimate, diphenhydramine
28
motion sickness, lesser morning sickness anti emetic properties is base on anti cholinergic, anti histamine and sedation
h2 antihistamines
29
potent antiemetics. blocks d2 receptor in ctz antagonize amorphin induced vomiting
neuroleptics
30
difficult or infrequent passage of stools
constipation
31
tx of constipations
anticholinergic, antacid, narcotics
32
laxatives
bulk forming, osmotic, stimulant, stool surfactant
33
indigestible, hydrophillic colloids that absorbs water forming or bulky emollient gels
bulk laxatives
34
do not give to pc with crohns diseas, obstruction, intestinal strictures
bulk laxatives
35
natural plant producs
psylium and methylcellulose
36
synthetic fibers
polycarbophil
37
soluble but not absorbable compound. results to increase stool liquidation
saline and osmotic laxatives
38
purgatives
magnesium citrate, sodium sulfate, milk of magnesia
39
magnesium oxide
milk of magnesia
40
reduce ammonia levels in hepatic encephalopathy
lactulose
41
rectal burning
glycerin
42
sorbitol
non absorbable
43
complete colonic cleansing before git endoscopy
polythylene glycol
44
induce bowel movements through direct stimulation of enteric ns, colonic electrolyte, fluid secretion
stimulant laxatives
45
not to be given in px with hpn, chf, and renal impairment
saline
46
aloe, senna, cascara
anthraquinone derivatives
47
side effects of anthraquinone derivatives
melanosis coli, brown pigmentation, chronic use
48
diphenylmethane derivatives
phenolphthalein, bisacodyl, castor oil
49
dulcolax
bisacodyl
50
phased out in market due to cardiac toxicity
phenolphthalein
51
hydrolyzed in small intestine local irritant that stimulates inyestinal motility
castor oil
52
soften stool materials, permits h2o and lipides to penetrate
stool surfactant agents
53
softeners
stool surfactant agents
54
example of stool surfactants
ducosate and glycerin supp
55
clear, viscous oil that lubricates fecal material
mineral oil
56
cannot be given to patients with bloody diarrhea, fever, and systemic toxicity
antidiarrheal
57
tx of fecal impaction and debilitated adults
mineral oil
58
side effects of mineral oil
aspiration, pneumonitis, impair absorption of fat-soluble vitamins
59
fat-soulble vitamins
ADEK
60
mild to moderate acute diarrhea control diarrhea caused by IBS and IBD
antidiarrheal
61
example of antidiarrheal
opoiod anatgonist, kaolin and pectin, colloidal bismuth, ocreotide, bind salts and binding resins
62
examples of bile salt resins
cholistyramine and colestipol
63
diarrhea caused by excess bile acids, crohn's disease and resection of terminal ileum
cholistyramine
64
SE of bile salt resins
bloating, flatulence, constipation, fecal impaction
65
half life of somatostatin
3 minutes
66
half life of ocreotides
1.5 hours
67
inhibits the secretion of gastrin, cholecystokinin, glucagon, growth hormone, insulin secretion, pancreatic polypeptide, vasoactive intestinal peptide, and 5ht3
somatostatin and ocreotide
68
inhibition of endocrine tumor
somatostatin and ocreotide
69
carceroid and VIPoma
endocrine tumor
70
SE of somatostatin and ocreotide
steatorrhea, abdominal pain, ADEK difficiency, nausea
71
blocks 5ht3 receptor in the affarebt neurons distention induced sensory and motor reflex activation colonic motility
serotonin 5ht3 receptor antagonist
72
diarrhea predominant ibs
serotonin 5ht3 receptor antagonist
73
adr of serotonin 5htr receptor antagonist
constipation, ischemic collitis
74
inhibits muscarinic cholinergic receptor in the enteric plexus; smooth muscles
antispasmodics
75
examples of antispasmodics
dicyclomine, hyoscyamine, tegaserod
76
hyosyamine
levsin
77
dicyclomine
bentyl
78
resembles serotonin in structure
tegaserod
79
tx for IBS with predominant constipation
tegaserod
80
IBD
inflammatory bowel disease
81
immune mediated chronic intestinal condition
inflammatory bowel disease
82
backwash ileitis
ulcerative colitis
83
involves the rectum, extends proximally to involve the colon
ulcerative colitis
84
mouth to anus; rectum is spared
crohn's disease
85
perirectal fistulas, fissures abscesses, anal stenosis
crohn's disease
86
tx for crohn's disease
aminosalicylates, azo compounds, mesalamine compounds
87
purine anti metabolite
azathioprine and 6-mercaptopurine
88
glucocorticoids
infliximab, tacrolimus, cyclosporine
89
mainstay of therapy for mild to moderate ulcerative colitis
aminosalicylates
90
examples of azo compounds
sulfasalazine, olsalazine, balsalazide
91
mesalamine compounds
pentasa, asacol, rowasa
92
reduces absorption of the oarent drug from the small intestine
azo compounds
93
resident bacteria cleanse the azo bonds by means of
azoreductase enzyme
94
5 asa group are bound together
sulfasalazine
95
bound to 4-aminobenzoyl-b-alanine secretory diarrhea
olsalazine
96
contains time release microgranules
pentasa
97
oated in ph-sensitive resinthat dissolves at ph7
asacol
98
delivered at high concentration to the rectum and the sigmoid colon
rowasa
99
side effect of mesalamin compounds
entestinal nephritis
100
induction and maintenance of remission of UC and CD post operative prophylaxis of cd
purine anti-metabolite